Stem cell and platelet rich plasma (PRP) therapies are considered as regenerative or bio medicines. They are minimally invasive and hence reduce the need for surgery. These therapies help stimulate, rebuild, and strengthen hair regrowth, instead of removing damaged tissue from the scalp.
Novel therapies for alopecia are preferred by dermatologists and patients over conventional drugs such as corticosteroids. Greater preference for these therapies arises from efficient and faster hair regrowth as compared to other corticosteroid treatments.

Market Analysis and Insights: Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market
In 2020, the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Scope and Market Size
The global Platelet Rich Plasma and Stem Cell Alopecia Treatment market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Androgenic Alopecia
Congenital Alopecia
Cicatricial Or Scarring Alopecia

Segment by Application
Hospital
Dermatology Clinic
Other

By Company
Kerastem
Eclipse
Regen Lab SA
Stemcell Technologies
RepliCel Life Sciences
Histogen
Glofinn Oy.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE